Navigation Links
Lexicon To Present At The BIO CEO & Investor Conference
Date:2/6/2013

0; All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 McGraw-Hill Education Professional, a leading ... technical, and medical communities, has announced the launch of ... application of the world-renowned medical education platform. ... App , available for download onto all iOS and ... to gain access to valuable AccessMedicine diagnostic ...
(Date:7/29/2014)... 2014 According to a new ... Fixation Devices Market - Global Forecast, Market Share, Size, ... orthopedic trauma fixation devices market is estimated at USD ... at a CAGR of 7.2% from 2014 to 2019, ... in 2020. Browse the Orthopedic Trauma Fixation ...
(Date:7/29/2014)... , July 29, 2014  Instrumentation Laboratory (IL) today announced ... new corporate logo. This is part of a comprehensive rebranding ... Founded in Boston, MA , in 1959, ... companies since 1992.  Other companies in the group include Inova ... Systelab ( Barcelona, Spain ).  Like IL, these ...
Breaking Medicine Technology:McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... SAN DIEGO, April 29, 2011 Halozyme Therapeutics, Inc. ... and commercializing products targeting the extracellular matrix , ... financial results on Friday, May 6, 2011 before the ... followed by a conference call with the investment community ...
... Pa., April 29, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... therapeutic and preventive vaccines against cancers and infectious diseases, announced ... conferences: JMP Securities Research Conference San ... Inovio Presentation Dr. J. Joseph Kim, ...
Cached Medicine Technology:Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6 2Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
(Date:7/29/2014)... 2014 Many people complain about their dependence ... each morning is put on glasses to see their clock ... individuals also may be dissatisfied with their vision even when ... may cause difficulty driving, especially at night due to glare. ... one’s golf ball, see the TV, sew or cross stitch, ...
(Date:7/29/2014)... Alan Mozes HealthDay Reporter ... autism patients with just a single dose of the hormone ... emotions, Japanese researchers report. Known as the "love hormone," ... bonding between lovers, and between mothers and their children. ... key area of the brain that has long been associated ...
(Date:7/29/2014)... During his 37 years in dental practice, Dr. Arthur ... a steady stream of college students shadow him in order ... on to dental school and some are now practicing dentistry ... college students find success. , For students interested in applying ... to see a realistic view of what goes on in ...
(Date:7/29/2014)... headache sufferers to record the severity and regularity of ... Griffith research study. , A new approach to the ... with their triggers and is being led by Professor ... Health program. , He has developed an approach designed ... their headaches called Learning to Cope with Triggers (LCT). ...
(Date:7/29/2014)... Palm Beach, Florida (PRWEB) July 29, 2014 ... new scholarship for law students this week. The scholarship will ... of abused children and their families. , Steinger, Iscoe and ... past abuse, and want tomorrow’s attorneys to do the same. ... States each year according to the nonprofit Childhelp ...
Breaking Medicine News(10 mins):Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:Arthur Bruce Dental Helps College Students 2Health News:Steinger, Iscoe & Greene Offers Child Advocate Scholarship 2
... early studies into a new treatment for patients with ... an anti-depression 'pacemaker' found the electrical device can significantly ... pacemaker, which is implanted in a person's chest, sends ... brain. The device was originally used to treat patients ...
... Hyderabad, Andhra Pradesh chief minister Chandrababu Naidu has set ... City’ in the port town of Vishakhapatnam. By providing ... hopes to attract global pharmaceutical companies to the city ... by 2005. The ‘Pharma City’ will be developed by ...
... reduces the number of seizures suffered by severe epileptics, a ... coil which was placed on the side of the head ... ,The use of high-frequency pulses has been blamed for triggering ... using low-frequency magnetism.The ten patients in the Gottingen study suffered ...
... found six genes which may play a role in breast ... to gauge an individual woman's risk of developing cancer by ... breast cancer cases are currently thought to be caused by ... firmly linked with some cases of inherited breast cancer, but ...
... to a new study combining a diet rich in ... blood pressure, even in those not suffering from hypertension. ... lead to significant health benefits.// Previous research has shown ... levels of homocysteine, an amino acid linked to heart ...
... disorder which they say is responsible for people who find ... findings could lead to new treatments for jet lag//, insomnia ... Utah say people who cannot stay awake much after 8.30pm ... a disorder called "familial advanced sleep-phase syndrome". This means the ...
Cached Medicine News:
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Medicine Products: